The Signals Research Suite is the first fully integrated SaaS platform. This solution is ideal for scientists working on new drug modalities or who want to expand the power of Signals Notebook across ...

Shares of Lumos Pharma rallied after investment firm Double Point Ventures agreed to buy the biopharmaceutical company for $38 million in cash plus potential milestone payments. Lumos shares rose 12% ...

The consignment of mephedrone worth Rs. 2.17 crores and 427.95 kilograms of semi processed mephedrone was seized by Surat and ...

Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases.

The former headquarters of a collapsed developer in North Wales could become an apart-hotel under new plans. GM Jones built ...

Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains, highlighting the urgent ...

Shares of Lumos Pharma were set to rise after investment firm Double Point Ventures agreed to buy the biopharmaceutical company for $38 million in cash plus potential milestone payments.

In conclusion, a demerger, like any major pivot, is a high-stakes, high-value moment where everything matters. Reconnect to ...

A multi-omics approach to identify biomarkers of response to the novel and selective SRC/YES1 inhibitor NXP900 ...

England's drug-cost regulator rejcted Eli Lilly's Alzheimer's drug for use in the country's public health system, marking the second time a treatment for the disease has been deemed too costly.

While two employees were gifted Grand Vitaras, 13 others received Tata Punch cars. The idea is to motivate the employees, ...